To meet the needs of enterprises to understand the latest achievements and industry trends in endoscopy, and to better support the development of the industry, Frost & SullivanFrost & SullivanFrost & Sullivan, abbreviated as 'Frost & Sullivan', joined handsMedtec ChinaTogether, we once again launched the high-end special seminar for the second quarter, focusing on the endoscope industry market and conducting in-depth exchanges around endoscope innovation achievements.
The exchange meeting has been held7month19The conference was successfully held in Beijing on the 1st. At this meeting, industry leaders from endoscope manufacturers, research institutions, and service providers shared their experiences and served as guests. On the day of the conference, there were nearly50Industry peers participated in the event, with most being corporate decision-makers and project leaders. The conference focused on cutting-edge trends and innovative development strategies in the endoscopic industry, and delved into the future trends and cooperation opportunities for China's endoscopic industry.
On-site topics&Guests' wonderful review
1
fattening
Partner and Managing Director of Greater China Region
Frost & Sullivan
Mr. Mao Hua analyzed the global investment and financing situation of medical endoscopes.
Title: Global Endoscopic Investment and Financing Analysis
Medical endoscopes are continuously developing towards clearer images, three-dimensionality, navigation, consumables, and ultra-fine technology. According to data, global and Chinese investment in the field of medical endoscopes is2021The year reached its peak, with a total global financing of8.98billion US dollars, with a total domestic financing of20.9RMB 10 billion. The number of financing events is in2022There was a decline after the New Year, but in the early financing roundsA(As of before that) the respective proportions were about55%(Globally) and38.5%(Country). Under the wave of national innovation policies and domestic substitution, the development of the medical endoscope industry has been rapid. It has not only revitalized traditional surgery at the surgical end but also injected new vitality into diagnosis and screening. In our country, the penetration rate of functional endoscopes continues to rise, up to2030The annual target is expected to be achieved23.6%The proportion of domestic products is increasing continuously, up to2030The annual target is expected to be achieved35.2%President Mao also pointed out that the innovation of endoscopes has never been about refining a single product. In addition to core optical technology and mechanical design and manufacturing technology, it is also necessary to integrate cutting-edge robotics andAIOnly by deeply integrating the auxiliary system can we embark on a new chapter in endoscope innovation.
2
Zhouguan Mountain
Investment Director
Hangzhou Kangji Medical Devices Co., Ltd.
Dr. Zhou Guanshan shared on the current development status and innovative explorations of endoscopy in China
Title: Current Development Status and Innovative Exploration of Endoscopic Industry
Dr. Zhou Guanshan emphasized the rapid development and future trends of the medical endoscopy industry during his speech. He mentioned that, from a technical perspective,CMOSThe iteration of image processing technology has broken the long-standing dominance of Japanese manufacturersCCDThe monopoly of technology has enabled domestic brands to make breakthroughs in high-end software and hardware intraocular lens products. In addition, the diversification of market demand has driven the development of disposable endoscopes, which can effectively reduce the risk of cross-infection, lower disinfection and maintenance costs, and improve surgical safety.
Dr. Zhou also pointed out that the market pattern is changing, with domestic rigid and flexible endoscopes gradually increasing their market share, narrowing the gap with international brands. Future development trends will move towards clarity, three-dimensionality, multifunctionality, and intelligence, promoting innovation and application of endoscopic technology.
3
Liu Lei
Directors and General Manager
Shanghai Jinhai Medical Technology Co., Ltd.
Mr. Liu Lei is responsible for4KIntroduction to endoscopic fluorescence imaging system
Title:4KResearch, Development and Clinical Application of Fluorescent Endoscopes
Advanced optical imaging and signal processing technologies help to create a unique “taste” The localization path. At the same time, President Liu also introduced it in detail for usAIResearch in the field of endoscopic technology includes intraoperative navigation, intelligent control, gesture recognition, etc. With the continuous evolution and innovation of technology,AIThe application prospects in the field of endoscopy are still very broad. In the future, withAIThe continuous improvement of technology and the growing demand for healthcare,AIThe commercial application in the field of laparoscopic diagnosis and treatment will continue to drive the development and progress of the medical industry, bringing more benefits to patients and healthcare professionals.
4
Huang Zundan
CEO
Shenzhen Haijian Medical Technology Co., Ltd.
Mr. Huang Zundan shared with everyone the opportunities for self-sufficiency and development of core endoscopic components
Title: Enhancing the Completeness and Resilience of the Industrial Chain: The Autonomous Supply and Development Opportunities of Endoscopic Core Components
President Huang pointed out that in the future, with the continuous improvement of clinical demand and the continuous reduction of product prices, disposable endoscopes will develop towards greater specialization and scale. Brand manufacturers will utilize their channel advantages to enter hospitals at the terminal level; production will develop through outsourced manufacturing models to better utilize resources and achieve large-scale development.
Roundtable discussion The atmosphere was enthusiastic
The roundtable discussion was chaired by Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China, and invited guests from four upstream and downstream enterprises in the endoscopic industry, including Chen Haixia, Executive Vice President of Novogene Medical, Sun Daguang, Vice President of PricewaterhouseCoopers Securities, Liu Jun, Executive Director of Huajie Gaojing Healthcare Industry Fund, and Shi Chengyong, Researcher at Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences. The guests discussed the development direction of China's endoscopic industry under the theme of "domestic and international dual circulation" and shared insights on innovation and internationalization of China's endoscopic industry.
The guests engaged in an in-depth discussion on the current innovation status, pain points, and breakthrough paths of the endoscopic industry in China.
Ms. Chen Haixia emphasized the importance of molecular fluorescence endoscopy technology and pointed out its precision in tumor diagnosis.
Mr. Sun Daguang stated that although the domestic endoscopic innovation ecosystem has initially taken shape, there are still deficiencies in aspects such as the localization of core components. It is recommended to strengthen collaborative innovation and intellectual property protection.
Mr. Liu Jun shared his investment logic, emphasizing the importance of technological innovation and clinical value, and suggested that enterprises strengthen academic promotion and the transformation of technical achievements.
Mr. Shi Chengyong introduced the current research status in the fields of endoscopic optics and mechanics
Finally, the guests unanimously agreed that innovation is the core driving force for the development of the endoscopic industry, and internationalization is an inevitable trend. Through collaborative innovation among upstream and downstream enterprises, as well as collaboration among industry, academia, research, and healthcare, China's endoscopic industry will embrace new development opportunities. Support from the government and capital markets is also indispensable, and a sound policy support system and investment and financing mechanism will provide strong support for the development of the endoscopic industry.
Project Roadshow The enterprise reaped rich rewards
On the judging panel, Mr. Cao Shiyue, General Manager of Research and Development at China Pharmaceutical Investment Co., Ltd., Mr. Xiong Shuirou, Partner of Yoyin Medical Fund, Mr. Liu Jun, Executive Director of Huajie Gaojing Medical Industry Fund, and Mr. Ling Zhongbao, Founding Partner of Zhi Fangda Medical Innovation Fund, were respectively invited.
The projects presented at this roadshow are as follows: General Manager He Songtao of Hengyang Dajing Medical Devices Technology Co., Ltd.4KWireless endoscopic camera system andAIImage enhancement platform;MetaCVTian Xue, the operational leader of Nanzhi Core Vision, brought a millimeter-level large-field-of-view thousandfold microscopic endoscope system, and Zhang Hongming, the technical leader of Beijing Youwei Medical Technology Co., Ltd., presented a confocal fluorescence endoscope system.
The roadshow companies reported on their project team composition, project technology, financing needs, etc. The judges and guests at the panel raised questions about the project's development potential, current output value, and core strengths. The discussion atmosphere at the scene was lively, and the roadshow companies gained a lot from it.
Frost & Sullivan will launch in the second half of this year: 'Blue Book on the Current Situation and Future Trends of the Global Endoscopic Industry', looking forward to the joint cooperation of endoscopic enterprises.
Frost & Sullivan has authored the 'Global Endoscopy Industry Development Status and Trend Insights Blue Book', aiming to analyze the key driving factors for endoscopy companies to accelerate their layout in the industry, discern the investment and financing trends and dynamics in the endoscopy sector, and discuss and contemplate the development direction of endoscopic technology from an all-round and multi-level perspective. The release and exchange activities of the blue book will further promote a deeper understanding among all parties in the market of the competitive landscape, industry environment, and ecosystem, jointly map the development panorama of the endoscopy industry with all parties in the market, and work together to promote the vigorous development of the global endoscopy industry.
To participate in supporting the "Blue Book on the Current Situation and Future Trends of the Global Endoscopic Industry Development," please scan the QR code below. We will get in touch with you!
More exciting photos from the event
